Daily Podcasts Video Research

Can weight-loss drugs help in cancer treatment? This Jewish organization is on the case

JL;DR SUMMARY Jewish breast and ovarian cancer organization Sharsheret is addressing the role of GLP-1 receptor agonists, like semaglutides (Ozempic and Wegovy), in cancer treatment. A way out west there was a fella, fella I want to tell you about, fella by the name of Jeff Lebowski. At least, that was the handle his lovin' parents gave him, but he never had much use for it himself. This Lebowski, he called himself the Dude. Now, Dude, that's a name no one would self-apply where I come from. But then, there was a lot about the Dude that didn't make a whole lot of sense to me. And a lot about where he lived, likewise. But then again, maybe that's why I found the place s'durned innarestin'.

JL;DR members get full summaries of all articles in the archive, including this one. Donate & start reading »

Tags

SharsheretBreast CancerObesityWeight LossOncologyCancer ResearchGlp 1 Receptor AgonistsBreast Cancer TreatmentJewish Health OrganizationsJewish Community Health

Places mentioned

New York City, New York, United States
"Its a very exciting time for all these medications, Dr. Barrie Weinstein, an endocrinologist and the medical director of Well by Messer, a New York City metabolic and wellness center specializing in weight loss, said on the Sharsheret webinar."
South Florida, Florida, United States
"Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago."

Support this source

This item was indexed and curated by Cairo, JL;DR's web crawler.
Cairo Item ID 49942
Cairo Source ID 42
Retrieved 2025-04-23 05:31:14 UTC
Curated 2025-04-23 08:32:16 UTC